KU-0060648
SIGMA/SML1257 - ≥98% (HPLC)
Synonym: 4-
CAS Number: 881375-00-4
Empirical Formula (Hill Notation): C33H34N4O4S
Molecular Weight: 582.71
MDL Number: MFCD17214218
Linear Formula: C33H34N4O4S
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to light brown |
| form | powder |
| InChI | 1S/C33H34N4O4S/c1-2-35-12 |
| InChI key | AATCBLYHOUOCTO-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | O=C(CN1CCN(CC)CC1)NC2=CC= |
| solubility | DMSO: 1 mg/mL, clear (warmed) |
| storage temp. | −20°C |
| Biochem/physiol Actions: | KU-0060648 is a very potent dual inhibitor of DNA-PK and PI3K. |
| Biochem/physiol Actions: | KU-0060648 is a very potent dual inhibitor of DNA-PK and PI3K. The IC50 values for inhibition of DNA-PK in MCF7 and SW620 cells are 19 and 170 nM, respectively. The compound KU-0060648 inhibits MCF7 PI3K activity with an IC50 of 39 nM, but is inactive against PI3K in SW620, suggesting a cell-dependent mechanism of inhibition. KU-0060648 increases sensitivity to DNA damaging cytotoxic drugs such as etoposide and doxorubicin in tumor cell lines expressing DNA-PK. KU-0060648 stimulates Cas9 (CRISPR associated protein 9) mediated genome editing by enhancing the rate of homology directed-repair (HDR) and decreasing the rate of NHEJ (non-homologous end-joining). |
| Biochem/physiol Actions: | KU-0060648 is observed to inhibit proliferation and initiate apoptosis in hepatocellular carcinoma. KU-0060648 is useful in chemotherapy as it increases the efficiency of double stranded breaks initiated by anticancer drugs. |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS06 |
| Signal word | Danger |
| Hazard statements | H301 |
| Precautionary statements | P264 - P270 - P301 + P310 + P330 - P405 - P501 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |


